Theriva Biologics, Inc. (TOVX) is a publicly traded Healthcare sector company. As of August 4, 2026, TOVX trades at $0.23 with a market cap of $9.64M and a P/E ratio of -0.10. TOVX moved +1.03% today. Year to date, TOVX is +5.85%; over the trailing twelve months it is -48.58%. Its 52-week range spans $0.16 to $2.08. Analyst consensus is buy with an average price target of $2.50. Rallies surfaces TOVX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TOVX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $0.23 |
| Market Cap | $9.64M |
| P/E Ratio | -0.10 |
| EPS | $-2.08 |
| Dividend Yield | 0.05% |
| 52-Week High | $2.08 |
| 52-Week Low | $0.16 |
| Volume | 57.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-23.74M |
| Gross Margin | 0.00% |
2 analysts cover TOVX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $2.50.